Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 3, 2005, Pages 348-353

  Ladero, José M ^a,c   Martínez, Carmen ^b   García Martin, Elena ^b   Fernández Arquero, Miguel ^a   López Alonso, Gustavo ^a   De La Concha, Emilio Gómez ^a   Díaz Rubio, Manuel ^a   Agúndez, José A G ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF EXTREMADURA   (Spain)

^c NONE   (Spain)

Author keywords

Alcoholic cirrhosis; Genetic polymorphism; Glutathione S transferase M1; Glutathione S transferase T1

Indexed keywords

GLUTATHIONE S TRANSFERASE THETA1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; ISOENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CHRONIC DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA DETERMINATION; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SPAIN;

EID: 16444381643     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520510012109     Document Type: Article

References (32)

1. Day CP. Who gets alcoholic liver disease: Nature or nurture? J R Coll Phys Lond 2000;34:557-62.
2. Borrás E, Coutelle C, Rosell A, Fernández-Muixi F, Broch M, Crosas B, et al. Genetic polymorphism of alcohol dehydrogenase in Europeans: The ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology 2000;31:984-9.
3. Blasco C, Caballería J, Parés A, Lligona A, Deulofeu R, Lluis J, et al. El polimorfismo genético de las enzimas que metabolizan el etanol no influye en el desarrollo de lesiones hepáticas alcohólicas [abstract]. Gastroenterol Hepatol 2002;25(Suppl 1):55.
4. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic hepatitis. Hepatology 1997; 26:143-6.
5. Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP. Interleukin 10 promoter region polymorphism and susceptibility to advanced alcoholic liver disease. Gut 2000; 46:540-5.
6. Ladero JM, Fernández-Arquero M, Tudela JI, Agúndez JAG, Diaz-Rubio M, Benítez J, et al. Single nucleotide polymorphisms and microsatellite alleles of tumor necrosis factor alpha and interleukin-10 genes and the risk of advanced alcoholic liver disease. Liver 2002; 22:245-51.
7. Eaton DL, Bammler TK. Glutathione S-transferases. In: Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelbaum M, editors. Metabolic drug interactions. Philadelphia, Pa.: Lippincott Williams & Wilkins; 2000. pp 175-89.
8. Seidegaard J, Pero RW, Stille B. Identification of the K trans-stilbene oxide-active glutathione transferase in human mononuclear leukocytes and in liver as GST1. Biochem Genet 1989;27:253-61.
9. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-6.
10. Rowe JD, Nieves E, Listowsky I. Subunit diversity and tissue distribution of human glutathione S-transferases: Interpretation based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem J 1997;325:481-6.
11. Haufroid V, Jakubowski M, Janasik B, Ligocka D, Buchet J-P, Bergamaschi E, et al. Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological exposure to styrene. Pharmacogenetics 2002; 12:691-702.
12. Danielson UH, Esterbauer H, Mannevik B. Structure-activity relationship of 4-hydroxyalkenals in the conjugation catalysed by mammalian glutathione transferases. Biochem J 1987;247:707.
13. Xiong P, Bondy ML, Li D, Shen H, Wang L-E, Singletary SE, et al. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: A case-control study. Cancer Res 2001;61:8465-9.
14. Varas MJ. Ultrasonography and liver cirrhosis. Rev Esp enferm Dig 2003;95:248-50.
15. Baranov VS, Ivaschenko T, Bakay B, Aseev M, Belotserkovskaya R, Baranova H, et al. Proportion of GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases. Hum Genet 1996;97:516-20.
16. Savolainen VT, Pjarinen J, Perola M, Penttila A, Karhunen PJ. Glutathione-S-transferase GST M1 "null" genotype and the risk of alcoholic liver disease. Alcohol Clin Exp Res 1996;20:1340-5.
17. Groppi A, Coutelle C, Fleury B, Iron A, Begueret J, Couzigou P. Glutathione S-transferase class mu in French alcoholic cirrhotic patients. Hum Genet 1991;87:628-30.
18. Rodrigo L, Alvarez V, Rodriguez M, Pérez R, Alvarez R, Coto E. N-acetyltransferase 2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: A case-control study. Scand J Gastroenterol 1999;34:303-7.
19. Frenzer A, Butler WJ, Norton ID, Wilson JS, Apte MV, Pirola RC, et al. Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis. J Gastroenterol Hepatol 2002;17:177-82.
20. Burim RV, Canalle R, Martinelli A, de L, Takahashi CS. Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis 2004;19:291-8.
21. Hartley DP, Ruth JA, Petersen DR. The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase. Arch Biochem Biophys 1995;316:197-205.
22. Hubascht I, Ridderstrom M, Mannervik B. Human glutathione transferase A4-4: An alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem J 1998;330:175-9.
23. Hiratsuka A, Tobita K, Saito H, Sakamoto Y, Nakano H, Ogura K, et al. (S)-preferential detoxification of 4-hydroxy-2(E)-nonenal enantiomers by hepatic glutathione S-transferase isoforms in guinea-pigs and rats. Biochem J 2001;355:237-44.
24. Cheng JZ, Yang Y, Singh SP, Singhal SS, Awasthi S, Pan SS, et al. Two distinct 4-hydroxynonenal metabolizing glutathione S-transferase isozymes are differentially expressed in human tissues. Biochem Biophys Res Commun 2001;282:1268-74.
25. Abei M, Harada S, Tanaka N, McNeil M, Osuga T. Immunohistochemical localization of human liver glutathione S-transferase (GST) isozymes with special reference to polymorphic GST1. Biochim Biophys Acta 1989;995:279-84.
26. Luckey SW, Petersen DR. Metabolism of 4-hydroxynonenal by rat Kupffer cells. Arch Biochem Biophys 2001;389:77-83.
27. Bredschneider M, Klein K, Mürdter TE, Marx C, Eichelbaum M, Nüssler A, et al. Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver. Consequences for enzyme expression and busulfan conjugation. Clin Pharmacol Ther 2002;71:479-87.
28. Tetlow N, Liu D, Board P. Polymorphism of human alpha class glutathione transferases. Pharmacogenetics 2001;11:609-17.
29. Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, et al. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 2001;11:663-9.
30. Guy CA, Hoogendoorn B, Smith SK, Coleman S, O'Donovan MC, Buckland PR. Promoter polymorphisms in glutathione-S-transferase genes affect transcription. Pharmacogenetics 2004;14:45-51.
31. Tyndale RF. Genetics of alcohol and tobacco use in humans. Ann Med 2003;35:94-121.
32. Verlaan M, te Morsche RH, Roelofs HM, Laheij RJ, Jansen JB, Peters WH, et al. Glutathione S-transferase Mu null genotype affords protection against alcohol induced chronic pancreatitis. Am J Med Genet 2003;120A(1):34-9.